Dr. Reddy's launches 40 mg doxycycline capsules for skin therapy in US market.
Dr. Reddy's Labs launches Doxycycline Capsules, a generic equivalent of ORACEA in the US market.
On Friday, Dr Reddy’s Laboratories Ltd. unveiled its introduction of Doxycycline Capsules, 40 mg into the U.S. market. As per the company’s official statement, these capsules serve as a therapeutic generic equivalent to ORACEA (doxycycline, USP) Capsules, 40 mg, which have been sanctioned by the U.S. Food and Drug Administration (USFDA).
Packaged in bottles of 30 capsules, Dr Reddy’s Doxycycline Capsules, 40 mg, offer an alternative option. ORACEA is a registered trademark of Galderma Holdings, S.A.
This medication functions as a broad-spectrum antibiotic, effectively combating infections instigated by bacteria and specific parasites. Its applications include the treatment of bacterial pneumonia, acne, chlamydia infections, Lyme disease, cholera, typhus, and syphilis, while also serving as a preventive measure against malaria.
| Follow the Hindeez on Google News |  |
| Follow the Hindeez channel on WhatsApp |  |
We hate spam as much as you do
© Hindeez 2024, All Rights Reserved
